mayur661
☆    

India,
2010-06-02 16:54
(5864 d 07:41 ago)

Posting: # 5410
Views: 7,908
 

 Macrolide Suspension BE [Study Per­for­mance]

We are performing Bioequivalence Study of macrolide Suspension with reference product. In every pilot BE study reference product show variation, while test product give uniform data. Due to this reason we are not getting correct bioequivalence? What is reson behind this reference product variation.


Edit: See here. [Helmut]
Dr_Dan
★★  

Germany,
2010-06-02 17:30
(5864 d 07:05 ago)

@ mayur661
Posting: # 5416
Views: 6,069
 

 Macrolide Suspension BE

Please give more information: study design, dose, formulation differences?

Kind regards and have a nice day
Dr_Dan
mayur661
☆    

India,
2010-06-03 07:38
(5863 d 16:57 ago)

@ Dr_Dan
Posting: # 5420
Views: 6,037
 

 Macrolide Suspension BE

❝ Please give more information: study design, dose, formulation differences?


Two way cross over design

200 mg/5mL

No iffrence in formulation only API have diffrent hydrate form other than refrence
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2010-06-03 14:14
(5863 d 10:21 ago)

@ mayur661
Posting: # 5424
Views: 6,164
 

 Forum's Policy

This is not a military camp; no need to use a command-and-report-language.
You are substantially decreasing your chances getting answers.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
127 visitors (0 registered, 127 guests [including 32 identified bots]).
Forum time: 00:36 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5